AtriCure, Inc. (NASDAQ:ATRC – Get Rating) has been assigned an average recommendation of “Buy” from the eleven brokerages that are covering the firm, MarketBeat reports. Three research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price target among brokers that […]